|
Pharma Stakeholders Call for Global Marketing Application
The FDA should work with other regulatory bodies, especially the European Medicines Agency (EMA), to create a single marketing application that would be accepted by multiple regulators, drug industry insiders urge.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives